Business Today US India IPR FDA Pharma Sector
Alchemy by E Kumar Sharma
Need focus on health, not medical insurance

So, while this may seem good news for the end consumer seeking better health, there is a risk of running disconnected elements and more important, the danger of missing out on a deeper issue of how we approach better health outcomes.

On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.
High profile investment melas by Indian states, backed by big numbers to showcase potential investor interest, are par-for-the-course today.